We are looking for 2 to 17 years of age to join a clinical research study to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or ulcerative colitis (UC) (including associated symptoms such as diarrhea, kidney stones, cramps, weight loss and/or eye pain), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
